Efficacy Study in Removing Excess Iron From the Heart
NCT00105495
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Thalassemia Major
Hemosiderosis
Interventions
DRUG:
Ferriprox (deferiprone)
DRUG:
Desferal (deferoxamine)
Sponsor
ApoPharma